FCN3 inhibits the progression of hepatocellular carcinoma by suppressing SBDS-mediated blockade of the p53 pathway

Hepatocellular carcinoma (HCC) is the third-leading cause of cancer deaths globally. Although considerable progress has been made in the treatment, clinical outcomes of HCC patients are still poor. Therefore, it is necessary to find novel prognostic factors upon which prevention and treatment strate...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Dong, Liu, Pengpeng, Wen, Junjun, Gu, Yang, Yang, Zhangshuo, Lan, Jianwei, Fan, Haining, Liu, Zhisu, Guo, Deliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830510/
https://www.ncbi.nlm.nih.gov/pubmed/36632465
http://dx.doi.org/10.7150/ijbs.69784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830510/
https://www.ncbi.nlm.nih.gov/pubmed/36632465
http://dx.doi.org/10.7150/ijbs.69784

Ejemplares similares